课题基金 / 基金详情

Tolerance of Kidney and Islet Transplants via the Mixed Chimerism Approach

Tolerance of Kidney and Islet Transplants via the Mixed Chimerism Approach
通过混合嵌合方法进行肾脏和胰岛移植的耐受性
批准号:
8432084
负责人:
TATSUO KAWAI
金额:
$64.36万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2017-07-31

项目摘要

项目成果

TATSUO KAWAI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (See instructions): Induction of specific immunologic tolerance is an ultimate goal of organ transplantation. Based on the conditioning regimen developed in our laboratory by decades-long research in nonhuman primates (NHP), we have now successfully achieved renal allograft tolerance in HLA mismatched human kidney transplant recipients via the mixed chimerism approach. However, limitations of this approach have been its inapplicability for deceased donor transplantation and the inability to induce tolerance of non-renal organs/cells. To extend this approach to deceased donor transplantation, we recently developed a novel strategy of
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bcl-2 and Mcl-1 inhibition for induction of hematopoietic chimerism and renal allograft tolerance without myelosuppression in nonhuman primates
  • 批准号:
    10634698
  • 项目类别:
  • 资助金额:
    $92.27万
  • 财政年份:
    2022
  • 负责人:
    TATSUO KAWAI
  • 依托单位:
Mcl-1 inhibition for induction of hematopoietic chimerism without nonselective myeloablative treatments in nonhuman primates
  • 批准号:
    10408176
  • 项目类别:
  • 资助金额:
    $20.38万
  • 财政年份:
    2021
  • 负责人:
    TATSUO KAWAI
  • 依托单位:
Mcl-1 inhibition for induction of hematopoietic chimerism without nonselective myeloablative treatments in nonhuman primates
  • 批准号:
    10288014
  • 项目类别:
  • 资助金额:
    $24.58万
  • 财政年份:
    2021
  • 负责人:
    TATSUO KAWAI
  • 依托单位:
Inhibition of BCL-2 for induction of mixed chimerism without myelosuppressive conditioning
  • 批准号:
    9168994
  • 项目类别:
  • 资助金额:
    $25.12万
  • 财政年份:
    2016
  • 负责人:
    TATSUO KAWAI
  • 依托单位:
海外基金